Table 4.
Multivariate logistic regression analyses of major thromboembolic events.
| Univariate Analysis | Multivariate Analysis | |||||
|---|---|---|---|---|---|---|
| OR | 95% CI | p Value | OR | 95% CI | p Value | |
| Age (yr) | 0.99 | 0.96–1.02 | 0.540 | |||
| Male sex | 2.71 | 1.09–6.92 | 0.031 | 2.43 | 0.97–6.11 | 0.058 |
| Diabetes | 1.85 | 0.92–3.71 | 0.083 | 1.79 | 0.88–3.66 | 0.110 |
| Hypertension | 1.36 | 0.64–2.89 | 0.427 | |||
| Coronary artery disease | 1.32 | 0.28–6.21 | 0.723 | |||
| Cerebral vascular disease | 1.20 | 0.14–10.27 | 0.866 | |||
| Chronic kidney disease | 0.64 | 0.08–5.13 | 0.677 | |||
| Massive transfusion | 1.38 | 0.69–2.73 | 0.358 | |||
| MELD-Na score | 0.99 | 0.95–1.03 | 0.678 | |||
| Duration of surgery (hour) | 1.22 | 1.05–1.43 | 0.012 | 1.22 | 1.04–1.44 | 0.014 |
| Cause for LT | ||||||
| HBV LC | 0.86 | 0.43–1.71 | 0.662 | |||
| HCV LC | 3.09 | 0.92–10.41 | 0.068 | |||
| Alcoholic LC | 0.95 | 0.47–1.91 | 0.881 | |||
| HCC | 1.53 | 0.77–3.01 | 0.223 | |||
| Blood products | ||||||
| a No transfusion | (reference) | |||||
| Cryoprecipitate | 2.09 | 0.85–5.11 | 0.107 | |||
| Fibrinogen concentrate use | 2.05 | 0.82–5.12 | 0.126 | |||
Abbreviations: OR, odds ratio; CI, confidence interval; HCC, hepatocellular cardinoma; MELD-Na, Model for End-stage Liver Disease-Sodium; LT, liver transplantation; LC, liver cirrhosis. a Patients who did not receive cryoprecipitate and fibrinogen concentrate but received pRBC or FFP transfusion.